In Memoriam: Bruce Furie — A Pioneer in Hemostasis Research
Thomas Reiser, Executive Director of the International Society on Thrombosis and Haemostasis (ISTH), reposted from ISTH on LinkedIn:
”I am deeply saddened by this tremendous loss.
Bruce Furie was a true giant in the field, dedicated leader and enormous contributor to International Society on Thrombosis and Haemostasis (ISTH) and the global thrombosis and hemostasis community, and a mentor to so many.
Sincere condolences to his life and career partner Dr. Barbara Furie and their family.
Bruce will be sorely missed.”
Quoting International Society on Thrombosis and Haemostasis‘s post:
”Bruce Furie, M.D., a longtime ISTH member and influential leader within the field of thrombosis and hemostasis, passed away on November 22, 2025.
Furie’s impact on the field of thrombosis and hemostasis was profound and far-reaching.
As a clinician, scientist and mentor, he contributed to many major discoveries, including the role of y-carboxylation in the synthesis of vitamin K-dependent blood coagulation proteins and the identification of P-selectin and its function as an adhesion molecule.
In 2021, the ISTH awarded honorary membership to Bruce and his wife and scientific collaborator Barbara Furie, Ph.D., recognizing decades of service to the Society.
The pair served as Co-Presidents of the ISTH 2009 Congress in Boston.
Bruce also served as ISTH Executive Officer and ISTH Secretary General.
In 2011, he received the ISTH Distinguished Career BACH Award.
Learn more about his legacy here.”
Stay updated with Hemostasis Today.
-
Sep 18, 2026, 17:48Ronak H. Mistry: Updated ASH Guidelines Bring New Focus to Iron Deficiency
-
Sep 18, 2026, 17:32Hassan Kawtharany: New Ferritin Cutoffs for the Diagnosis of Iron Deficiency With or Without Anemia
-
Sep 18, 2026, 17:20Abhishek G P: GAVE as an Important Cause of Chronic Gastrointestinal Blood Loss
-
Sep 18, 2026, 17:08Irem Karaman Sebin: ASH 2026 Changes a Key Concept in Iron Deficiency
-
Sep 18, 2026, 16:51Adarsh Krishnan Sundara Rajan: Is VTE the Most Underdiagnosed Critical Threat in Modern Healthcare?
-
Sep 18, 2026, 16:19CRISPR and Hemophilia: The Next Frontier of In Vivo Gene Editing
-
Sep 18, 2026, 16:13Christian Irsara: PF4 Immunothrombosis Following Natural Adenovirus Infection
-
Sep 18, 2026, 16:10Leo Nicolai։ The Spleen Emerges as a Key Regulator of Thromboinflammation
-
Sep 18, 2026, 16:05Targeting Factor XI to Reduce Thrombosis Without Compromising Hemostasis – ISTH